This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Mergers & Acquisitions

Aug. 27, 2014

Cravath, Davis Polk handle InterMune sale to Roche

Brisbane-based drug developer InterMune Inc. tapped a New York-based team of attorneys at Cravath, Swaine & Moore LLP to handle its $8.3 billion sale to Swiss pharmaceutical giant Roche Holding AG.


By Dominic Fracassa


Daily Journal Staff Writer


Brisbane-based drug developer InterMune Inc. tapped a New York-based team of attorneys at Cravath, Swaine & Moore LLP to handle its $8.3 billion sale to Swiss pharmaceutical giant Roche Holding AG.


The all-cash deal, announced Sunday, would help Roche bolster its portfolio of respiratory drugs, the company said in a statement.


Partners Faiza J. Saeed and Ting S. Chen led Cravath&#...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up